ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors with Losses in Extra of $100K to Safe Counsel Before Necessary March 14 Deadline in Securities Class Action – PCRX – Tunisia News Gazette
NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a world investor rights legislation agency, reminds purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, each dates inclusive (the “Class Period”), of the essential March 14, 2025 lead plaintiff deadline. SOContinue Reading